BIOMARIN PHARMACEUTICAL INC (BMRN)
US09061G1013 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 205.41M | 167.65M | 141.60M | -64.10M | 859.10M | |||
| Depreciation Amortization | 105.34M | 104.39M | 102.00M | 108.00M | 105.20M | |||
| Income Taxes - Deferred | -38.30M | -44.98M | -52.10M | -15.60M | -888.90M | |||
| Change In Working Capital | -225.32M | -336.54M | -96.40M | 66.00M | -224.40M | |||
| Interest Paid | N/A | 10.30M | 10.30M | 10.40M | 12.20M | |||
| Taxes Paid | N/A | 73.31M | 54.40M | 18.20M | 9.00M | |||
| Other non cash items | 233.01M | 268.75M | 80.80M | 210.20M | 234.40M | |||
| OPERATING CASH FLOW | 280.13M | 159.26M | 175.90M | 304.50M | 85.40M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -116.92M | -107.61M | -131.50M | -119.20M | -137.50M | |||
| Other Investing Activity | 21.43M | -3.63M | 111.50M | -247.10M | 83.90M | |||
| INVESTING CASH FLOW | -95.48M | -111.24M | -20.00M | -366.30M | -53.60M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.33M | -2.29M | -2.60M | -3.00M | 203.80M | |||
| Stock Issued/Repurchased | 55.35M | 69.35M | 69.30M | 49.20M | 21.90M | |||
| Other Financing Activity | -74.84M | -85.79M | -85.40M | -46.20M | -44.60M | |||
| FINANCING CASH FLOW | -20.82M | -18.73M | -18.70M | 0.00 | 181.10M | |||
| Exchange Rate Effect | 3.04M | 1.31M | 0.00 | -100.00K | -1.20M | |||
| CHANGE IN CASH | 166.87M | 30.60M | 137.20M | -61.90M | 211.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 280.13M | 159.26M | 175.90M | 304.50M | 85.40M | |||
| Capital Expenditure | -116.92M | -107.61M | -131.50M | -119.20M | -137.50M | |||
| FREE CASH FLOW | 163.21M | 51.65M | 44.40M | 185.30M | -52.10M | |||
All data in USD